Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 16,889,600 | 13,090,300 | 12,509,900 | 11,558,800 | 10,393,100 |
| Cost of Goods | 9,397,601 | 7,561,200 | 7,214,400 | 6,764,800 | 6,131,600 |
| Gross Profit | 7,491,999 | 5,529,100 | 5,295,500 | 4,794,000 | 4,261,500 |
| Operating Expenses | 4,989,600 | 3,919,700 | 3,813,800 | 3,544,000 | 3,074,000 |
| Operating Income | 2,503,000 | 1,609,600 | 1,482,100 | 1,250,800 | 1,188,100 |
| Other Income | -415,800 | -290,100 | -212,700 | -118,000 | -100,400 |
| Pre-tax Income | 2,087,200 | 1,319,500 | 1,269,400 | 1,132,800 | 1,087,700 |
| Income Tax | 191,700 | 40,400 | 11,000 | 109,400 | 101,600 |
| Net Income Continuous | 1,895,500 | 1,279,100 | 1,258,400 | 1,023,400 | 986,100 |
| Net Income Discontinuous | -1,100 | -5,800 | -80,500 | 306,500 | 49,500 |
| Net Income | $1,894,400 | $1,273,300 | $1,177,900 | $1,329,900 | $1,035,600 |
| EPS Basic Total Ops | 4.76 | 3.53 | 3.24 | 3.49 | 2.57 |
| EPS Basic Continuous Ops | 4.76 | 3.55 | 3.46 | 2.69 | 2.45 |
| EPS Basic Discontinuous Ops | 0.00 | -0.02 | -0.22 | 0.80 | 0.12 |
| EPS Diluted Total Ops | 4.71 | 3.48 | 3.21 | 3.46 | 2.53 |
| EPS Diluted Continuous Ops | 4.71 | 3.50 | 3.43 | 2.66 | 2.41 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.02 | -0.22 | 0.80 | 0.12 |
| EBITDA(a) | $4,187,799 | $2,609,500 | $2,465,802 | $2,110,400 | $1,927,800 |